In China, due to the regional disequilibrium in the social economic support and the accessibility of high standard healthcare, PSA test and conventional ultrasound-guided prostate biopsy will remain to be the major diagnostic tools for prostate cancer for quite a period of time. The gene discussed is KLK3; the disease is Familial prostate cancer.